Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical
Olympus Corporation, a global MedTech company committed to making people’s lives healthier, safer and more […]
Genascence Receives $11.6 Million Award From California Institute for Regenerative Medicine to Help Advance its Lead Gene Therapy Program in Knee Osteoarthritis
Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene […]
Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer
Phio Pharmaceuticals, a clinical-stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to […]
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
MEI Pharma, a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity […]
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
AbbVie and Capsida Biotherapeutics today announced an expanded strategic collaboration to develop genetic medicines for […]
AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and […]
Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)
Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of […]
Dawn Health partners with leading Pharmaceutical Company, Novartis, to Transform Chronic Care
Dawn Health, a global leader in digital health, has announced a strategic partnership with Novartis, […]
Lineage Enters Into Option and License Agreement With Eterna Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
Lineage Cell Therapeutics, a clinical-stage biotechnology company developing allogeneic cell therapies to replace and restore […]
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more